ELOX 8-K 2026-08-11

Eloxx Pharmaceuticals, Inc. (ELOX) 8-K dated 2026-08-11 — accession 0001193125-26-345032.

Eloxx Pharmaceuticals, Inc. (ELOX) is a biotechnology company listed on US.

Eloxx Pharmaceuticals, Inc. filed a 8-K on 2026-08-11. Accession 0001193125-26-345032.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ELOX revenue for 2025-12-31 was $0. Net income was -$6.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ELOX currently screens at market cap $314.

Not investment advice. The ELOX SEC hub lists recent forms. The stock page is the research view.